Cargando…
Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome
Atherosclerosis is a chronic inflammatory disease characterized by a complex interplay between innate and adaptive immunity. Dendritic cells (DCs) play a key role in T-cell activation and regulation by promoting a tolerogenic environment through the expression of the immunosuppressive enzyme indolea...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796013/ https://www.ncbi.nlm.nih.gov/pubmed/29278387 http://dx.doi.org/10.3390/ijms19010063 |
_version_ | 1783297412517855232 |
---|---|
author | Zara, Chiara Severino, Anna Flego, Davide Ruggio, Aureliano Pedicino, Daniela Giglio, Ada Francesca Trotta, Francesco Lucci, Claudia D’Amario, Domenico Vinci, Ramona Pisano, Eugenia La Rosa, Giulio Biasucci, Luigi Marzio Crea, Filippo Liuzzo, Giovanna |
author_facet | Zara, Chiara Severino, Anna Flego, Davide Ruggio, Aureliano Pedicino, Daniela Giglio, Ada Francesca Trotta, Francesco Lucci, Claudia D’Amario, Domenico Vinci, Ramona Pisano, Eugenia La Rosa, Giulio Biasucci, Luigi Marzio Crea, Filippo Liuzzo, Giovanna |
author_sort | Zara, Chiara |
collection | PubMed |
description | Atherosclerosis is a chronic inflammatory disease characterized by a complex interplay between innate and adaptive immunity. Dendritic cells (DCs) play a key role in T-cell activation and regulation by promoting a tolerogenic environment through the expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme involved in tryptophan catabolism. IDO expression and activity was analyzed in monocytes derived DCs (MDDCs) from non-ST segment elevation myocardial infarction (NSTEMI) patients, stable angina (SA) patients and healthy controls (HC) by real-time quantitative polymerase chain reaction (RT-qPCR) before and after in vitro maturation with lipopolysaccharide (LPS). The amount of tryptophan catabolite; kynurenine; was evaluated in the culture supernatants of mature-MDDCs by ELISA assay. Autologous mixed lymphocyte reaction (MLR) between mature-MDDCs and naïve T-cells was carried out to study the differentiation towards T-helper 1 (Th1) and induced regulatory T-cells (iTreg). Analysis of IDO mRNA transcripts in mature-MDDCs revealed a significant reduction in cells isolated from NSTEMI (625.0 ± 128.2; mean ± SEM) as compared with those from SA (958.5 ± 218.3; p = 0.041) and from HC (1183.6 ± 231.6; p = 0.034). Furthermore; the concentration of kynurenine was lower in NSTEMI patients (2.78 ± 0.2) and SA (2.98 ± 0.25) as compared with HC (5.1 ± 0.69 ng/mL; p = 0.002 and p = 0.016; respectively). When IDO-competent mature-MDDCs were co-cultured with allogeneic naïve T-cells, the ratio between the percentage of generated Th1 and iTreg was higher in NSTEMI (4.4 ± 2.9) than in SA (1.8 ± 0.6; p = 0.056) and HC (0.9 ± 0.3; p = 0.008). In NSTEMI, the tolerogenic mechanism of the immune response related to IDO production by activated MDDCs is altered, supporting their role in T-cell dysregulation. |
format | Online Article Text |
id | pubmed-5796013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57960132018-02-09 Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome Zara, Chiara Severino, Anna Flego, Davide Ruggio, Aureliano Pedicino, Daniela Giglio, Ada Francesca Trotta, Francesco Lucci, Claudia D’Amario, Domenico Vinci, Ramona Pisano, Eugenia La Rosa, Giulio Biasucci, Luigi Marzio Crea, Filippo Liuzzo, Giovanna Int J Mol Sci Article Atherosclerosis is a chronic inflammatory disease characterized by a complex interplay between innate and adaptive immunity. Dendritic cells (DCs) play a key role in T-cell activation and regulation by promoting a tolerogenic environment through the expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme involved in tryptophan catabolism. IDO expression and activity was analyzed in monocytes derived DCs (MDDCs) from non-ST segment elevation myocardial infarction (NSTEMI) patients, stable angina (SA) patients and healthy controls (HC) by real-time quantitative polymerase chain reaction (RT-qPCR) before and after in vitro maturation with lipopolysaccharide (LPS). The amount of tryptophan catabolite; kynurenine; was evaluated in the culture supernatants of mature-MDDCs by ELISA assay. Autologous mixed lymphocyte reaction (MLR) between mature-MDDCs and naïve T-cells was carried out to study the differentiation towards T-helper 1 (Th1) and induced regulatory T-cells (iTreg). Analysis of IDO mRNA transcripts in mature-MDDCs revealed a significant reduction in cells isolated from NSTEMI (625.0 ± 128.2; mean ± SEM) as compared with those from SA (958.5 ± 218.3; p = 0.041) and from HC (1183.6 ± 231.6; p = 0.034). Furthermore; the concentration of kynurenine was lower in NSTEMI patients (2.78 ± 0.2) and SA (2.98 ± 0.25) as compared with HC (5.1 ± 0.69 ng/mL; p = 0.002 and p = 0.016; respectively). When IDO-competent mature-MDDCs were co-cultured with allogeneic naïve T-cells, the ratio between the percentage of generated Th1 and iTreg was higher in NSTEMI (4.4 ± 2.9) than in SA (1.8 ± 0.6; p = 0.056) and HC (0.9 ± 0.3; p = 0.008). In NSTEMI, the tolerogenic mechanism of the immune response related to IDO production by activated MDDCs is altered, supporting their role in T-cell dysregulation. MDPI 2017-12-26 /pmc/articles/PMC5796013/ /pubmed/29278387 http://dx.doi.org/10.3390/ijms19010063 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zara, Chiara Severino, Anna Flego, Davide Ruggio, Aureliano Pedicino, Daniela Giglio, Ada Francesca Trotta, Francesco Lucci, Claudia D’Amario, Domenico Vinci, Ramona Pisano, Eugenia La Rosa, Giulio Biasucci, Luigi Marzio Crea, Filippo Liuzzo, Giovanna Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome |
title | Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome |
title_full | Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome |
title_fullStr | Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome |
title_full_unstemmed | Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome |
title_short | Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome |
title_sort | indoleamine 2,3-dioxygenase (ido) enzyme links innate immunity and altered t-cell differentiation in non-st segment elevation acute coronary syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796013/ https://www.ncbi.nlm.nih.gov/pubmed/29278387 http://dx.doi.org/10.3390/ijms19010063 |
work_keys_str_mv | AT zarachiara indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT severinoanna indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT flegodavide indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT ruggioaureliano indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT pedicinodaniela indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT giglioadafrancesca indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT trottafrancesco indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT lucciclaudia indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT damariodomenico indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT vinciramona indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT pisanoeugenia indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT larosagiulio indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT biasucciluigimarzio indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT creafilippo indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome AT liuzzogiovanna indoleamine23dioxygenaseidoenzymelinksinnateimmunityandalteredtcelldifferentiationinnonstsegmentelevationacutecoronarysyndrome |